BTX
$0.51
Brooklyn Immunotherapeutics
($.02)
(3.56%)
BTX
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus: $0.00
Revenue: N/A
Friday
Sep 30
After the close
What do you expect when BTX reports earnings?
Where is BTX's stock price going from here?
Analysts
Pivots
Resistance
$0.61
$0.59
$0.56
Support
$0.51
$0.49
$0.46
Description
Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.
